reac-technology
reac-technology

Terms of Use and Legal Notice

Last updated: June 3, 2025

1. Intellectual Property

REAC® Technology was created by Rinaldi Fontani Institute.

ASMED Srl, is the only certified company authorized to manufacture medical devices based on REAC® Technology (Radio Electric Asymmetric Conveyer). The company operates globally, both directly and indirectly, through subsidiaries/controlled companies, joint ventures, licensing agreements, and distribution agreements.

All content available on reactechnology.com, including but not limited to text, graphics, logos, images, videos, downloadable documents, source code, layouts, and any other materials (collectively, the “Content”), is the exclusive property of the Owner or its licensors and is protected under applicable Italian and international copyright, trademark, and intellectual property laws.
Any reproduction, distribution, modification, publication, transmission, sale, use, or exploitation of the Content, in whole or in part, without the prior written authorization of the Owner is strictly prohibited.

2. Use of the Website

Users agree to use the Website in a lawful, diligent, and compliant manner in accordance with these Terms and Conditions. In particular, users shall not:

  • use the Website for fraudulent purposes or in any unlawful manner;

  • attempt to access restricted data or systems connected to the Website;

  • upload or disseminate viruses, malware, or any other harmful code.

3. Disclaimer of Liability

The Owner makes every effort to ensure the accuracy and timeliness of the content published on the Website. However, no express or implied warranties are given regarding the accuracy, completeness, reliability, or availability of the Website or its content.
Under no circumstances shall the Owner be held liable for any direct, indirect, incidental, consequential, or punitive damages arising from the use or inability to use the Website, including but not limited to errors, omissions, service interruptions, technical failures, or data loss.

4. Third-Party Links

The Website may contain hyperlinks to third-party websites. The Owner exercises no control over such sites and disclaims any responsibility for their content, terms of use, or privacy policies.

5. Indemnification

Users agree to indemnify and hold harmless the Owner, its representatives, collaborators, and partners from and against any claims, legal actions, liabilities, losses, or damages (including legal fees) arising from:

  • improper use of the Website or its content;

  • violation of these Terms and Conditions;

  • infringement of third-party rights, including intellectual property rights.

6. Amendments

The Owner reserves the right to amend these Terms and Conditions at any time by updating their content on the Website. Any changes shall become effective immediately upon publication. Continued use of the Website constitutes implicit acceptance of the updated Terms and Conditions.

7. Governing Law and Jurisdiction

These Terms and Conditions are governed by Italian law. Any disputes concerning their validity, interpretation, or enforcement shall fall under the exclusive jurisdiction of the Court of Florence, with express waiver of any other applicable jurisdiction.

8. Legal Notice

Website Ownership
This website is operated by REAC® Technology, with registered office at Viale Belfiore, 43 - 50144 Florence - Italy, contactable via email at info@reactechnology.com.

Editorial Responsibility
The editorial responsibility for the content published on this Website is held by the Owner, unless otherwise stated. Any external contributions are published under the exclusive responsibility of the respective authors.

Medical Content Disclaimer
The information contained on this Website is intended solely for general informational and educational purposes. It is not intended to substitute professional medical advice, diagnosis, or treatment. Users should always seek the advice of a qualified healthcare provider regarding any medical condition.
No health-related information provided on this Website should be interpreted as a medical recommendation or prescription. The Owner assumes no responsibility for the misuse or misinterpretation of such information.

Trademarks and Logos
All trademarks, trade names, logos, and other distinctive signs appearing on the Website are the property of their respective owners. Unauthorized use is strictly prohibited.

Contact

For any information regarding these Terms and Conditions, please contact the Owner at: info@reactechnology.com

Dr. Vania Fontani

dr-vania-fontani-rinaldi-fontani-institute

Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.

She has dedicated her career to research and the development of innovative technologies for human well-being.

Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.

In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.

Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity

Learn more:
• Publications: PubMed – Rinaldi S, Fontani V

Prof. Salvatore Rinaldi

dr-salvatore-rinaldi-rinaldi-fontani-institu

Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316

Profile and Mission

Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.

 

Research Milestones

Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:


Regenerative Medicine:

  • Direct cellular reprogramming through epigenetic modulation of
    endogenous bioelectrical activity with REAC technology.
  • Radiofrequency energy loop primes cardiac, neuronal, and skeletal muscle
    differentiation in mouse embryonic stem cells: a new tool for improving tissue
    regeneration. Cell Transplant. 2012;21(6):1225-33. doi: 10.3727/096368911X600966.
  • Radio electric conveyed fields directly reprogram human dermal skin fibroblasts
    toward cardiac, neuronal, and skeletal muscle-like lineages. Cell Transplant.
    2013;22(7):1227-35. doi: 10.3727/096368912X657297.
  • Neurological morphofunctional differentiation induced by REAC technology in PC12. A
    neuro protective model for Parkinson's disease. Sci Rep. 2015 May 15:5:10439. doi:
    10.1038/srep10439.

Anti-Senescence and Longevity:

  • REAC technology and hyaluron synthase 2, an interesting network to slow down stem
    cell senescence. Sci Rep. 2016 Jun 24:6:28682. doi: 10.1038/srep28682.
  • Stem cell senescence. Effects of REAC technology on telomerase-independent and
    telomerase-dependent pathways. Sci Rep. 2014 Sep 16:4:6373. doi:
    10.1038/srep06373.
  • Anti-senescence efficacy of radio-electric asymmetric conveyer technology. Age
    (Dordr). 2014 Feb;36(1):9-20. doi: 10.1007/s11357-013-9537-8.

Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:

  • REAC technology modifies pathological neuroinflammation and motor behaviour in an
    Alzheimer's disease mouse model. Sci Rep. 2016 Oct 24:6:35719. doi:
    10.1038/srep35719.
  • Radio Electric Asymmetric Conveyer Technology Modulates Neuroinflammation in a
    Mouse Model of Neurodegeneration. Neurosci Bull. 2018 Apr;34(2):270-282. doi:
    10.1007/s12264-017-0188-0

Scientific Vision

Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.

Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V